Drug Discovery Biology theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.
ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.
Chem Rev. 2022 Sep 14;122(17):13989-14017. doi: 10.1021/acs.chemrev.1c00837. Epub 2022 Jul 18.
Membrane proteins are highly diverse in both structure and function and can, therefore, present different challenges for structure determination. They are biologically important for cells and organisms as gatekeepers for information and molecule transfer across membranes, but each class of membrane proteins can present unique obstacles to structure determination. Historically, many membrane protein structures have been investigated using highly engineered constructs or using larger fusion proteins to improve solubility and/or increase particle size. Other strategies included the deconstruction of the full-length protein to target smaller soluble domains. These manipulations were often required for crystal formation to support X-ray crystallography or to circumvent lower resolution due to high noise and dynamic motions of protein subdomains. However, recent revolutions in membrane protein biochemistry and cryo-electron microscopy now provide an opportunity to solve high resolution structures of both large, >1 megadalton (MDa), and small, <100 kDa (kDa), drug targets in near-native conditions, routinely reaching resolutions around or below 3 Å. This review provides insights into how the recent advances in membrane biology and biochemistry, as well as technical advances in cryo-electron microscopy, help us to solve structures of a large variety of membrane protein groups, from small receptors to large transporters and more complex machineries.
膜蛋白在结构和功能上高度多样化,因此在结构测定方面可能会带来不同的挑战。它们作为信息和分子跨膜传递的守门员,对细胞和生物体具有重要的生物学意义,但每一类膜蛋白在结构测定方面都可能带来独特的障碍。历史上,许多膜蛋白结构的研究都采用了高度工程化的构建体或使用更大的融合蛋白来提高溶解度和/或增加颗粒大小。其他策略包括将全长蛋白解构为更小的可溶性结构域,以目标更小的可溶性结构域。这些操作通常是为了促进晶体形成,以支持 X 射线晶体学,或避免由于蛋白质亚结构域的高噪声和动态运动导致分辨率降低。然而,膜蛋白生物化学和冷冻电镜的最新进展为在近天然条件下解决大(>1 兆道尔顿(MDa)和小(<100 kDa)药物靶标的高分辨率结构提供了机会,通常可达到 3 Å 左右或以下的分辨率。本文综述了膜生物学和生物化学的最新进展,以及冷冻电镜技术的进步如何帮助我们解决各种膜蛋白的结构,从小型受体到大型转运蛋白和更复杂的机器。